#inflammatory
Yale-Led Clinical Trial Investigates Anti-Inflammatory Drug Adalimumab to Prevent Parkinson’s Disease in High-Risk Patients
In a groundbreaking approach to neurodegenerative disease research, a team of Yale-led scientists has launched a major clinical...
Yale-Led Clinical Trial Investigates Anti-Inflammatory Drug Adalimumab to Prevent Parkinson’s Disease in At-Risk Patients
In a groundbreaking endeavor that bridges neurology, sleep medicine, and immunology, researchers at the Yale School of Medicine...
Yale Researchers Launch Landmark Clinical Trial to Test Anti-Inflammatory Drug Adalimumab for Preventing Parkinson’s Disease
In a groundbreaking endeavor that bridges neurology, immunology, and sleep medicine, a team of Yale-led researchers has officially...
Yale-Led Clinical Trial Investigates Anti-Inflammatory Drug Adalimumab to Prevent Parkinson’s Disease in High-Risk Patients
27 Oktober 2026
A groundbreaking clinical trial led by researchers at the Yale School of Medicine has officially launched to investigate whether the...
